Skip to main content

AHRQ's National Guideline Clearinghouse is a public resource for summaries of evidence-based clinical practice guidelines.

May 29, 2017

Guideline Synthesis

  • Diabetic Foot Ulcers: Wound Management

Guideline Summaries

  • New and Updated American College of Radiology Guidelines on:
    • Chronic Chest Pain—High Probability of Coronary Artery Disease
    • Chronic Hip Pain
    • Chronic Liver Disease
    • Chylothorax Treatment Planning
    • Dyspnea—Suspected Cardiac Origin
    • Evaluation of Nipple Discharge

View All New This Week

May 29, 2017

Conference News

Grant Opportunity

G-I-N NA Webinar Series: USPSTF Methods for Making Recommendations for Diverse Populations: When: May 30, 2017 12:30PM ET (11:30PM CT; 10:30AM MT; 9:30AM PT); Register: External Web Site Policy; The U.S. Preventive Services Task Force (USPSTF) makes evidence-based recommendations on clinical preventive services for primary care clinicians and their patients. The Evidence-based Practice Centers (EPCs) support the USPSTF with systematic reviews that are used as the basis for the recommendations. Hear what one EPC and the USPSTF have done to improve recommendations for diverse populations.

U.S. FDA Advisory

FDA Advisory

May 16, 2017: Canagliflozin (Invokana, Invokamet) External Web Site Policy: Based on new data from two large clinical trials, the FDA has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. FDA is requiring new warnings, including the most prominent Boxed Warning, to be added to the canagliflozin drug labels to describe this risk.

View All Announcements

About NGC

NGC supports AHRQ's mission to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable by providing objective, detailed information on clinical practice guidelines, and to further their dissemination, implementation, and use in order to inform health care decisions.